English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Community

+ Community
Amanda Rupp | May 4, 2016

CMS encourages improvements for nursing facility residents

+ Technology/Innovation
Amanda Rupp | May 4, 2016

AbbVie attains Stemcentrx compound to treat lung cancer

+ Regulatory
Amanda Rupp | May 4, 2016

FDA approves name change for Brintellix brand

+ Community
Amanda Rupp | May 4, 2016

ADA launches second annual National Get Fit Don’t Sit Day

+ Regulatory
Amanda Rupp | May 4, 2016

FDA publishes final guidance for menu labeling

+ Community
Amanda Rupp | May 4, 2016

2016 Sheila Essey Award given to King's College neurology expert

+ Regulatory
Amanda Rupp | May 3, 2016

Hallucination, delusion drug for Parkinson’s patients receives FDA approval

+ Technology/Innovation
Amanda Rupp | May 3, 2016

Positive phase I data revealed for Ebola vaccine trial

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 458
  • 459
  • 460
  • 461
  • 462
  • 463
  • 464
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily